The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
[5–9] As the medications in both arms of the GOOD ... was to determine whether Gaviscon® could be a relevant alternative to omeprazole 20 mg in patients suffering from mild-to-moderate episodic ...
has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage certain kinds of pain. The drug, suzetrigine, received the FDA's official ...